CD44 and breast carcinoma: Furthermore, improved magnetic resonance imaging (MRI) and photothermal ablation, both in vitro and in vivo, demonstrated substantial photothermal effects specifically targeting CD44 HA receptor-overexpressing breast cancer [94].